HPV

  1. Vaccines are one of the most effective global public health interventions ever.
    Published: April 2019
    Type: Article
  2. When more vaccine manufacturers are able to enter the market, supply increases while cost decreases. PATH supports emerging market vaccine manufacturers to do just that, improving access to lifesaving vaccines.
    Published: March 2019
    Type: Article
  3. The United States has a long history of leadership in global immunization. This educational fact sheet created by PATH and several advocacy partners highlights US government efforts in global immunization, including support for Gavi, the Vaccine Alliance; UNICEF; and the World Health Organization, as well as immunization activities carried out by the US Agency for International Development, US Department of Defense, and various agencies within the Department of Health and Human Services.
    Published: March 2019
    Type: Resource Page
  4. This fact sheet outlines PATH's role in providing technical assistance to countries for the planning, implementation, and evaluation of human papillomavirus (HPV) vaccination programs. The PATH HPV vaccine team’s activities are channeled through four primary work streams: Gavi, the Vaccine Alliance application support; program planning and implementation; evaluation; and cervical cancer prevention and control strategies.
    Published: September 2018
    Type: Resource Page
  5. There is broad recognition of the growing and inequitable burden of cervical cancer in low-resource countries, and uptake of new screening and treatment alternatives for adult women and human papillomavirus (HPV) vaccines for young adolescent girls is on the rise. For the first time in history the elimination of the disease is within reach, and on May 19, 2018, WHO Director-General, Dr. Tedros Adhanom Ghebreyesus made a global call for action on cervical cancer elimination. This fact sheet summarizes PATH's current work and future priorities.
    Published: July 2018
    Type: Resource Page
  6. Aisha was wearing her blue school uniform and wiping tears from her face. She’d just been vaccinated, but it wasn’t the shot that upset her. She was crying because her mother died of the very disease she was being protected from—cervical cancer.
    Published: June 2018
    Type: Article
  7. Leading health and research institutions come together to evaluate the evidence for potential single-dose HPV vaccination schedule
    Published: January 2018
    Type: Announcement
  8. PATH’s Scale-Up project works to expand the use of human papillomavirus (HPV) testing for cervical cancer prevention. Based on PATH’s experience implementing the careHPV™ test in Central America, these tools provide guidance for organizing a quality assurance program to screening programs adopting the careHPV test.
    Published: November 2017
    Type: Resource Page
  9. This brochure outlines PATH's work in China, where we collaborate with government agencies, nongovernmental organizations, research institutes, and manufacturers to improve health and save lives. With technical assistance from PATH, China is becoming a leading supplier of lifesaving health technologies and products for use in low-resource settings. Programmatic areas include tuberculosis, vaccines and immunization, neglected tropical diseases, and reproductive health.
    Published: February 2017
    Type: Resource Page
  10. This brochure outlines PATH’s work to improve health in Uganda. Key areas of focus include cervical cancer prevention, detection, and treatment; vaccines and immunization, including supply chain improvements; advocacy to improve the quality and availability of health care services; and introduction of Sayana® Press, a popular new form of injectable contraceptive.
    Published: January 2017
    Type: Resource Page
Load more